An organoselenium compound inhibits Staphylococcus aureus biofilms on hemodialysis catheters in vivo

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 972-978

  Tran, Phat L ^a   Lowry, Nathan ^a   Campbell, Thomas ^a   Reid, Ted W ^a   Webster, Daniel R ^a   Tobin, Eric ^b   Aslani, Arash ^b   Mosley, Thomas ^c   Dertien, Janet ^a   Colmer Hamood, Jane A ^a   Hamood, Abdul N ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b SPIRE CORPORATION   (United States)

^c Selenium Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ORGANOSELENIUM DERIVATIVE; SELENOCYANATODIACETIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BIOFILM; CATHETER INFECTION; CELL CULTURE; CONTINUOUS CULTURE; CONTROLLED STUDY; DIALYSIS CATHETER; FEMALE; HEMODIALYSIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BIOFILMS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EQUIPMENT CONTAMINATION; ORGANOSELENIUM COMPOUNDS; RENAL DIALYSIS; STAPHYLOCOCCUS AUREUS;

EID: 84856068184     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05680-11     Document Type: Article

References (36)

1. Akoh JA. 2011. Vascular access infections: epidemiology, diagnosis, and management. Curr. Infect. Dis. Rep. 13:324-332.
2. Bach A, et al. 1993. Prevention of catheter-related infections by antiseptic bonding. J. Surg. Res. 55:640-646. (Pubitemid 24003071)
3. Betjes MG. 2011. Prevention of catheter-related bloodstream infection in patients on hemodialysis. Nat. Rev. Nephrol. 7:257-265.
4. Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S. 2009. Antimicrobial and antibiofilm efficacy of triclosan and dispersinB combination. J. Antimicrob. Chemother. 64:88-93.
5. Davies DG, et al. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295-298. (Pubitemid 28178075)
6. Donlan RM. 2001. Biofilms and device-associated infections. Emerg. Infect. Dis. 7:277-281. (Pubitemid 32374344)
7. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193. (Pubitemid 34303762)
8. Dünser MW, et al. 2005. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters. Anesth. Analg. 101:1778-1784. (Pubitemid 41720636)
9. Edgeworth J. 2009. Intravascular catheter infections. J. Hosp. Infect. 73: 323-330.
10. Frasca D, Dahyot-Fizelier C, Mimoz O. 2010. Prevention of central venous catheter-related infection in the intensive care unit. Crit. Care 14:212.
11. Hammond A, Dertien J, Colmer-Hamood JA, Griswold JA, Hamood AN. 2010. Serum inhibits P. aeruginosa biofilm formation on plastic surfaces and intravenous catheters. J. Surg. Res. 159:735-746.
12. Hentzer M, et al. 2001. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol. 183:5395-5401. (Pubitemid 32802613)
13. ISO. 2006. Biological evaluation of medical devices. Part 11. Tests for systemic toxicity. ISO 10993-11:2006. International Organization for Standardization, Geneva, Switzerland.
14. Heydorn A, et al. 2000. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146:2395-2407.
15. Jaeger K, et al. 2005. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter. Ann. Hematol. 84:258-262. (Pubitemid 40425073)
16. Kadurugamuwa JL, et al. 2003. Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection. Antimicrob. Agents Chemother. 47:3130-3137. (Pubitemid 37229568)
17. Leid JG, et al. 2005. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J. Immunol. 175:7512-7518. (Pubitemid 41713449)
18. Logghe C, et al. 1997. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J. Hosp. Infect. 37:145-156. (Pubitemid 27472630)
19. Malone CL, et al. 2009. Fluorescent reporters for Staphylococcus aureus. J. Microbiol. Methods 77:251-260.
20. Mathews SM, et al. 2006. Prevention of bacterial colonization of contact lenses with covalently attached selenium and effects on the rabbit cornea. Cornea 25:806-814. (Pubitemid 44657256)
21. Matsukawa M, Greenberg EP. 2004. Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. J. Bacteriol. 186:4449-4456. (Pubitemid 38891007)
22. Mermel LA. 2000. Prevention of intravascular catheter-related infections. Ann. Intern. Med. 132:391- 402. (Erratum, 133:395.)
23. Morales M, Méndez-Alvarez S, Martín-López JV, Marrero C, Freytes CO. 2004. Biofilm: the microbial "bunker" for intravascular catheter-related infection. Support. Care Cancer 12:701-707. (Pubitemid 39362648)
24. Nishikawa K, Takasu A, Morita K, Tsumori H, Sakamoto T. 2010. Deposits on the intraluminal surface and bacterial growth in central venous catheters. J. Hosp. Infect. 75:19-22.
25. O'Grady NP, et al. 2011. Guidelines for the prevention of intravascular catheter-related infections. Clin. Infect. Dis. 52:e162-e193.
26. O'Toole GA, Kolter R. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449-461. (Pubitemid 28218392)
27. Prospero E, et al. 2006. Cluster of Pseudomonas aeruginosa catheter-related bloodstream infections traced to contaminated multidose heparinized saline solutions in a medical ward. Int. J. Hyg. Environ. Health 209:553-556. (Pubitemid 44584768)
28. Ramritu P, et al. 2008. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am. J. Infect. Control. 36:104-117. (Pubitemid 351296068)
29. Reid ME, et al. 2004. A report of high-dose selenium supplementation: response and toxicities. J. Trace Elem. Med. Biol. 18:69-74. (Pubitemid 39285967)
30. Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB. 2008. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J. Antimicrob. Chemother. 61:869-876. (Pubitemid 351426072)
31. Sandoe JA, Witherden IR, Cove JH, Heritage J, Wilcox MH. 2003. Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo. J. Med. Microbiol. 52:547-550. (Pubitemid 36871891)
32. Schaber JA, et al. 2007. Diversity of biofilms produced by quorum-sensing-deficient clinical isolates of Pseudomonas aeruginosa. J. Med. Microbiol. 56:738-748. (Pubitemid 46911227)
33. Song JY, et al. 2011. Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections. J. Med. Microbiol. 60:605-611.
34. Theaker C, et al. 2002. Comparison of bacterial colonization rates of antiseptic impregnated and pure polymer central venous catheters in the critically ill. J. Hosp. Infect. 52:310-312. (Pubitemid 38001915)
35. Tran PL, et al. 2009. Organoselenium coating on cellulose inhibits the formation of biofilms by Pseudomonas aeruginosa and Staphylococcus aureus. Appl. Environ. Microbiol. 75:3586-3592.
36. Zhang L, Gowardman J, Rickard CM. 2011. Impact of microbial attachment on intravascular catheter-related infections. Int. J. Antimicrob. Agents 38:9-15.